These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 9281596

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The effect of antitumor trans-[PtCl2(E-iminoether)2] on B-->Z transition in DNA.
    Zaludová R, Natile G, Brabec V.
    Anticancer Drug Des; 1997 Jun; 12(4):295-309. PubMed ID: 9199661
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. DNA adducts of antitumor trans-[PtCl2 (E-imino ether)2].
    Brabec V, Vrána O, Nováková O, Kleinwächter V, Intini FP, Coluccia M, Natile G.
    Nucleic Acids Res; 1996 Jan 15; 24(2):336-41. PubMed ID: 8628659
    [Abstract] [Full Text] [Related]

  • 7. Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.
    Najajreh Y, Kasparkova J, Marini V, Gibson D, Brabec V.
    J Biol Inorg Chem; 2005 Nov 15; 10(7):722-31. PubMed ID: 16208494
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxicity and DNA binding mode of new platinum-iminoether derivatives with different configuration at the iminoether ligands.
    Boccarelli A, Coluccia M, Intini FP, Natile G, Locker D, Leng M.
    Anticancer Drug Des; 1999 Jun 15; 14(3):253-64. PubMed ID: 10500500
    [Abstract] [Full Text] [Related]

  • 9. The induction of lysis in lysogenic strains of Escherichia coli by a new antitumor transplatin derivative and its DNA interactions.
    Brabec V, Pracharova J, Novakova O, Gibson D, Kasparkova J.
    Dalton Trans; 2015 Feb 28; 44(8):3573-82. PubMed ID: 25406573
    [Abstract] [Full Text] [Related]

  • 10. Replacement of an NH(3) by an iminoether in transplatin makes an antitumor drug from an inactive compound.
    Leng M, Locker D, Giraud-Panis MJ, Schwartz A, Intini FP, Natile G, Pisano C, Boccarelli A, Giordano D, Coluccia M.
    Mol Pharmacol; 2000 Dec 28; 58(6):1525-35. PubMed ID: 11093793
    [Abstract] [Full Text] [Related]

  • 11. Platinum(II) complexes containing iminoethers: a trans platinum antitumour agent.
    Coluccia M, Boccarelli A, Mariggiò MA, Cardellicchio N, Caputo P, Intini FP, Natile G.
    Chem Biol Interact; 1995 Dec 22; 98(3):251-66. PubMed ID: 8548863
    [Abstract] [Full Text] [Related]

  • 12. DNA interactions of new cytotoxic tetrafunctional dinuclear platinum complex trans,trans-[{PtCl2(NH3)}2(piperazine)].
    Brabec V, Christofis P, Slámová M, Kostrhunová H, Nováková O, Najajreh Y, Gibson D, Kaspárková J.
    Biochem Pharmacol; 2007 Jun 15; 73(12):1887-900. PubMed ID: 17400194
    [Abstract] [Full Text] [Related]

  • 13. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
    Kasparkova J, Marini V, Najajreh Y, Gibson D, Brabec V.
    Biochemistry; 2003 May 27; 42(20):6321-32. PubMed ID: 12755637
    [Abstract] [Full Text] [Related]

  • 14. Steric control of DNA interstrand cross-link sites of trans platinum complexes: specificity can be dictated by planar nonleaving groups.
    Brabec V, Neplechova K, Kasparkova J, Farrell N.
    J Biol Inorg Chem; 2000 Jun 27; 5(3):364-8. PubMed ID: 10907747
    [Abstract] [Full Text] [Related]

  • 15. Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand. Mechanistic studies on antitumor action.
    Kasparkova J, Novakova O, Marini V, Najajreh Y, Gibson D, Perez JM, Brabec V.
    J Biol Chem; 2003 Nov 28; 278(48):47516-25. PubMed ID: 12970368
    [Abstract] [Full Text] [Related]

  • 16. In vitro and in vivo antitumour activity and cellular pharmacological properties of new platinum-iminoether complexes with different configuration at the iminoether ligands.
    Coluccia M, Nassi A, Boccarelli A, Giordano D, Cardellicchio N, Locker D, Leng M, Sivo M, Intini FP, Natile G.
    J Inorg Biochem; 1999 Oct 28; 77(1-2):31-5. PubMed ID: 10626350
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. DNA and glutathione interactions in cell-free media of asymmetric platinum(II) complexes cis- and trans-[PtCl2(isopropylamine)(1-methylimidazole)]: relations to their different antitumor effects.
    Suchánková T, Vojtísková M, Reedijk J, Brabec V, Kaspárková J.
    J Biol Inorg Chem; 2009 Jan 28; 14(1):75-87. PubMed ID: 18777181
    [Abstract] [Full Text] [Related]

  • 19. Novel apoptosis-inducing trans-platinum piperidine derivatives: synthesis and biological characterization.
    Khazanov E, Barenholz Y, Gibson D, Najajreh Y.
    J Med Chem; 2002 Nov 21; 45(24):5196-204. PubMed ID: 12431047
    [Abstract] [Full Text] [Related]

  • 20. DNA interactions of new antitumor platinum complexes with trans geometry activated by a 2-metylbutylamine or sec-butylamine ligand.
    Prokop R, Kasparkova J, Novakova O, Marini V, Pizarro AM, Navarro-Ranninger C, Brabec V.
    Biochem Pharmacol; 2004 Mar 15; 67(6):1097-109. PubMed ID: 15006546
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.